Literature DB >> 4383454

5-hydroxytryptamine participation in the vagal inhibitory innervation of the stomach.

E Bülbring, M D Gershon.   

Abstract

1. Intraluminal pressure was recorded from the isolated guinea-pig and mouse stomach with the vagus and sympathetic nerves attached.2. The response to vagal stimulation, which consists of an excitatory and an inhibitory component, resembled the response to 5-hydroxytryptamine (5-HT), which has no direct action on the muscle but acts on intrinsic excitatory and inhibitory ganglia.3. In the presence of hyoscine, the effect of vagal stimulation, of nicotinic compounds and of 5-HT were all purely relaxant. Competitive block of ganglionic receptors for acetylcholine reduced the vagal relaxation without antagonizing 5-HT. Specific desensitization of ganglionic receptors for 5-HT reduced the vagal relaxation without antagonizing nicotinic compounds.4. During the early phase of the blocking action of nicotine, responses to vagal stimulation and to 5-HT were both abolished. As the non-specific antagonism changed to the later phase of specific antagonism to acetylcholine, the inhibitory (but not the excitatory) component of the vagal response recovered partially, in parallel with the recovery of the relaxant effect of 5-HT.5. The vagal inhibitory effect was completely abolished only when competitive block of acetylcholine receptors was combined with desensitization of 5-HT receptors.6. Stimulation of the mouse stomach (after asphyxiation of the mucosa and exclusion of the luminal content) in the presence of hyoscine caused the release of 5-HT; this release was blocked by tetrodotoxin.7. The results, together with previous observations that 5-HT is contained within preganglionic nerve fibres in the myenteric plexus, are consistent with the hypothesis that 5-HT, with acetylcholine, may be a neurotransmitter in the vagal inhibitory innervation of the stomach.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4383454      PMCID: PMC1365545          DOI: 10.1113/jphysiol.1967.sp008334

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  A NEW CLASS OF 5-HYDROXYTRYPTAMINE ANTAGONISTS.

Authors:  L GYERMEK
Journal:  J Med Chem       Date:  1964-05       Impact factor: 7.446

2.  ELECTROPHYSIOLOGICAL OBSERVATIONS ON THE MOTOR INNERVATION OF THE SMOOTH MUSCLE CELLS IN THE GUINEA-PIG VAS DEFERENS.

Authors:  H KURIYAMA
Journal:  J Physiol       Date:  1963-11       Impact factor: 5.182

3.  Tryptamine receptors.

Authors:  J H GADDUM
Journal:  J Physiol       Date:  1953-02-27       Impact factor: 5.182

4.  Effects of tetrodotoxin on innervated smooth muscle preparations.

Authors:  M D Gershon
Journal:  Br J Pharmacol Chemother       Date:  1967-03

5.  The release of 5-hydroxytryptamine from the rat stomach in vitro.

Authors:  A Bennett; A Bucknell; A C Dean
Journal:  J Physiol       Date:  1966-01       Impact factor: 5.182

6.  Pharmacological properties of phenyldiguanide and other amidine derivatives in relation to those of 5-hydroxytryptamine.

Authors:  F N FASTIER; M A McDOWALL; H WAAL
Journal:  Br J Pharmacol Chemother       Date:  1959-12

7.  Actions of dimethylphenylpiperazinium.

Authors:  H W LING
Journal:  Br J Pharmacol Chemother       Date:  1959-12

8.  Radioisotopic studies of the binding, exchange, and distribution of 5-hydroxytryptamine synthesized from its radioactive precursor.

Authors:  M D Gershon; L L Ross
Journal:  J Physiol       Date:  1966-10       Impact factor: 5.182

9.  5-Hydroxytryptamine and transmission in sympathetic ganglia.

Authors:  E C HERTZLER
Journal:  Br J Pharmacol Chemother       Date:  1961-12

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  50 in total

Review 1.  Receptors of the enteric nervous system: potential targets for drug therapy.

Authors:  J Tack
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Functional Dyspepsia: Impaired Fundic Accommodation.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

Review 3.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

4.  The peristaltic reflex: an analysis of the nerve pathways and their pharmacology.

Authors:  M Costa; J B Furness
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-07       Impact factor: 3.000

5.  Nature of the vagal inhibitory innervation to the lower esophageal sphincter.

Authors:  R K Goyal; S Rattan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

6.  Discrimination between nicotinic receptors in vertebrate ganglia and skeletal muscle by alpha-bungarotoxin and cobra venoms.

Authors:  S Bursztajn; M D Gershon
Journal:  J Physiol       Date:  1977-07       Impact factor: 5.182

7.  In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs.

Authors:  P Janssen; N H Prins; B Moreaux; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

8.  Studies of the interaction of 5-hydroxytryptamine and the perivascular innervation of the guinea-pig caecum.

Authors:  A B Drakontide; M D Gershon
Journal:  Br J Pharmacol       Date:  1972-07       Impact factor: 8.739

9.  Mechanism of action of dopamine on the guinea-pig gastro-oesophageal junction in vitro.

Authors:  B Cox; C Ennis
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

10.  Fluorescent histochemistry of the teleost gut: evidence for the presence of serotonergic neurones.

Authors:  A H Watson
Journal:  Cell Tissue Res       Date:  1979-03-09       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.